Rachele Berria

机构：Wilmington University, AstraZeneca (United States)

发表论文 55 篇 · 总被引 8655 次 · h-index 30

代表论文

• Fenofibrate Reduces Systemic Inflammation Markers Independent of Its Effects on Lipid and Glucose Metabolism in Patients with the Metabolic Syndrome (2010 · The Journal of Clinical Endocrinology & Metabolism · 被引 162)
• Weight Loss, Glycemic Control, and Changes in Cardiovascular Biomarkers in Patients With Type 2 Diabetes Receiving Incretin Therapies or Insulin in a Large Cohort Database (2010 · Diabetes Care · 被引 155)
• Treatment With the Human Once-Weekly Glucagon-Like Peptide-1 Analog Taspoglutide in Combination With Metformin Improves Glycemic Control and Lowers Body Weight in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Alone (2009 · Diabetes Care · 被引 117)
• Rates of Hypoglycemia Predicted in Patients with Type 2 Diabetes on Insulin Glargine 300 U/ml Versus First- and Second-Generation Basal Insulin Analogs: The Real-World LIGHTNING Study (2019 · Diabetes Therapy · 被引 65)
• Global Relationship between the Proteome and Transcriptome of Human Skeletal Muscle (2008 · Journal of Proteome Research · 被引 39)
• Insulin therapy in type 2 diabetes mellitus: a practical approach for primary care physicians and other health care professionals. (2013 · PubMed · 被引 38)